Reed Vickie S
- SEC CIK
- 0001405637
No open-market purchases or sales filed in the past year.
Current role at each company
- EVOK Evoke Pharma IncDirectoras of Dec 17, 2025
- DMK DMK Pharmaceuticals CorpDirectoras of May 26, 2022
- MRTX Mirati Therapeutics, Inc.SVP, Chief Accounting Officeras of Jan 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reed Vickie S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRTX Mirati Therapeutics, Inc.
SVP, Chief Accounting Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Reed Vickie SSVP, Chief Accounting Officer | SSale | −533 | $120.48 | −$64.2K | −3.4%15.4K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | Reed Vickie SSVP, Chief Accounting Officer | SSale | −345 | $135.94 | −$46.9K | −3.2%10.5K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Reed Vickie SSVP, Chief Accounting Officer | SSale | −758 | $147.74 | −$112.0K | −6.5%10.9K after |